Clinical Trial Update: Safety and Immunogenicity Study of Ad26-ENVA and Ad35-ENV HIV Vaccines in Healthy HIV-uninfected Adults [Phase 1]

View source ↗

Summary

A Phase 1 safety and immunogenicity study of two HIV vaccines, Ad26-ENVA and Ad35-ENV, in healthy HIV-uninfected adults has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Ad26-ENVA
• Ad35-ENV

Snippet

Sponsor: International AIDS Vaccine Initiative | Conditions: HIV Infections | Phase 1 | Status: COMPLETED